<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-type="olc" bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-KEL25345-G96-TR-7S9">
    <metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 S1862 IS: Optimizing Research Progress Hope And New Cures Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2025-05-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
        <distribution-code>II</distribution-code>
        <congress>119th CONGRESS</congress>
        <session>1st Session</session>
        <legis-num>S. 1862</legis-num>
        <current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
        <action>
            <action-date date="20250522">May 22, 2025</action-date>
            <action-desc><sponsor name-id="S317">Mr. Barrasso</sponsor> (for himself and <cosponsor name-id="S359">Mr. Heinrich</cosponsor>) introduced the following bill; which
                was read twice and referred to the <committee-name committee-id="SSFI00">Committee
                    on Finance</committee-name></action-desc>
        </action>
        <legis-type>A BILL</legis-type>
        <official-title>To amend title XI of the Social Security Act to expand and clarify the
            exclusion for orphan drugs under the Drug Price Negotiation Program.</official-title>
    </form>
    <legis-body style="OLC" display-enacting-clause="yes-display-enacting-clause" id="H9FAB3549B3ED4EFBB10747ED334359AA">
        <section section-type="section-one" id="H4C22ED0B7F744F8A8FD873C3ACC045B3">
            <enum>1.</enum>
            <header>Short title</header>
 <text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Optimizing Research Progress Hope And New Cures Act</short-title></quote> or the <quote><short-title>ORPHAN Cures Act</short-title></quote>.</text>
        </section>
        <section id="H41DBA9C405A4413AA0EF17EDE7503E93">
            <enum>2.</enum>
            <header>Expanding and clarifying the exclusion for orphan drugs under the Drug Price
                Negotiation Program</header>
 <text display-inline="no-display-inline">Section 1192(e) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320f-1">42 U.S.C. 1320f–1(e)</external-xref>) is amended—</text>
            <paragraph id="HE3ED2A483CDB45858B11E3076CE50645">
                <enum>(1)</enum>
 <text>in paragraph (1), by adding at the end the following new subparagraph:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="HD1B42BD2B64949F891CE37B12C65FB9F"> <subparagraph id="H308EF310E6BD4E9E99BE134DAAB38C20"> <enum>(C)</enum> <header>Treatment of former orphan drugs</header> <text display-inline="yes-display-inline">In calculating the amount of time that has elapsed with respect to the approval of a drug or licensure of a biological product under subparagraph (A)(ii) and subparagraph (B)(ii), respectively, the Secretary shall not take into account any period during which such drug or product was a drug described in paragraph (3)(A).</text>
                    </subparagraph>
                    <after-quoted-block>; and</after-quoted-block>
                </quoted-block>
            </paragraph>
            <paragraph id="HDB2D0C828ACE46D5BDCC22E2BF74B5C7">
                <enum>(2)</enum>
 <text>in paragraph (3)(A)—</text> <subparagraph id="H0C74AE1F2860460798DD929825E48ADE"> <enum>(A)</enum> <text>by striking <quote>only one rare disease or condition</quote> and inserting <quote>one or more rare diseases or conditions</quote>; and</text>
                </subparagraph>
                <subparagraph id="HBD075D1C16664B9DB0CBD5BEB805CD0E">
                    <enum>(B)</enum>
 <text>by striking <quote>such disease or condition</quote> and inserting <quote>one or more rare diseases or conditions (as such term is defined in section 526(a)(2) of the Federal Food, Drug, and Cosmetic Act)</quote>.</text>
                </subparagraph>
            </paragraph>
        </section>
    </legis-body>
</bill>

